Citations

Clear

6273 citation(s) found for "To, Andrew".

Glomerular Volume and Glomerulosclerosis at Different Depths within the Human Kidney
Đenić, Aleksandar , Ricaurte, Luisa , Lopez, Camden , Narasimhan, Ramya , Lerman, Lilach O. , Thompson, R. Houston, Kremers, Walter K. , Rule, Andrew D. , Rule, Andrew D , Denic, Aleksandar , Lopez, Camden L , Kremers, Walter K , Lieske, John C.

Mayo Clinic

Journal of the American Society of Nephrology | July 5, 2019 | Volume: 30 | Issue: 8 | Pages: 1471-1480

10.1681/asn.2019020183 | PMID 31278193 Get It

Significance Statement Research investigating glomerular morphology in different cortical regions has been limited to animal models and a small number of human autopsy kidneys. In this study, the authors used tissue from living patients who underwent a radical nephrectomy (for a renal tumor) to characterize glomerular morphology and glomerulosclerosis by cortical depth. They found that glomerular volume and glomerulosclerosis differed by depth across three cortical regions (superficial, middle, and deep). Although most clinical associations with glomerulosclerosis and glomerulomegaly did not differ by cortical depth, there were important exceptions. Age-related glomerulosclerosis appeared to be an ischemic process and was more evident in the superficial (subcapsular) region. Diabetes-related glomerulosclerosis was more evident in the deep (juxtamedullary) region. Obesity more strongly associated with larger glomeruli in the superficial region. Background Age, CKD risk factors, and kidney function are associated with larger glomerular volume and a higher percentage of globally sclerotic glomeruli. Knowledge of how these associations may differ by cortical depth is limited. Methods To investigate glomerular volume and glomerulosclerosis across different depths of cortex, we studied wedge sections of the renal parenchyma from 812 patients who underwent a radical nephrectomy (for a tumor), separately characterizing glomeruli in the superficial (subcapsular), middle, and deep (juxtamedullary) regions. We compared the association of mean nonsclerotic glomerular volume and of glomerulosclerosis (measured as the percentage of globally sclerotic glomeruli) with age, obesity, diabetes, smoking, kidney function, and structural pathology in the superficial, middle, and deep regions. Results The superficial, middle, and deep regions showed significant differences in glomerular volume (0.0025, 0.0031, and 0.0028 µ m 3 , respectively) and in glomerulosclerosis (18%, 7%, and 11%, respectively). There was a marked increase in glomerulosclerosis with age in the superficial region, but larger glomerular volume was not associated with age at any cortical depth. Glomerulosclerosis associated more strongly with arteriosclerosis and ischemic-appearing glomeruli in the superficial region. Hypertension, lower eGFR, and interstitial fibrosis associated with glomerulosclerosis and glomerular volume to a similar extent at any depth. Diabetes and proteinuria more strongly associated with glomerulosclerosis in the deep and middle regions, respectively, but neither associated with glomerular volume differently by depth. Obesity associated more strongly with glomerular volume in the superficial cortex. Conclusions Most clinical characteristic show similar associations with glomerulosclerosis and glomerulomegaly at different cortical depths. Exceptions include age-related glomerulosclerosis, which appears to be an ischemic process and is more predominant in the superficial region.
Hi-Plex2: A Simple and Robust Approach to Targeted Sequencing-Based Genetic Screening
Hammet, Fleur, Mahmood, Khalid , Green, Thomas R, Nguyen‐Dumont, Tú , Buchanan, Daniel D. , Lonie, Andrew , Nathanson, Katherine L. , Pope, Bernard J. , Buchanan, Daniel D , Nathanson, Katherine L , Nguyen-Dumont, Tu , Pope, Bernard J , Southey, Melissa C. , Couch, Fergus J. , Park, Daniel J.

Mayo Clinic

BioTechniques | July 3, 2019 | Volume: 67 | Issue: 3 | Pages: 118-122

10.2144/btn-2019-0026 | PMID 31267764 Get It

Enablers and Barriers to Implementing ICU Follow-Up Clinics and Peer Support Groups Following Critical Illness: The Thrive Collaboratives*
McPeake, Joanne , Hibbert, Elizabeth , Boehm, Leanne M. , Aparanji, Krishna, Bakhru, Rita N. , Bastin, Anthony J. , Beesley, Sarah J. , Beveridge, Lynne , Butcher, Brad W. , Drumright, Kelly, Eaton, Tammy L. , Firshman, Penelope , Fritschle, Andrew, Hope, Aluko A. , Johnson, Annie, Kenes, Michael T. , Khan, Babar , Kloos, Janet A. , Kross, Erin K. , MacTavish, Pamela , Meyer, Joel , Montgomery-Yates, Ashley , Quasim, Tara , Saft, Howard L., Slack, Andrew, Stollings, Joanna L. , Weinhouse, Gerald L., Whitten, Jessica, Netzer, Giora, Hopkins, Ramona O., Iwashyna, Theodore J. , Sevin, Carla M. , Haines, Kimberley , Farley, Thomas, Holdsworth, Clare, Mikkelsen, Mark E.

Mayo Clinic

Critical Care Medicine | June 28, 2019 | Volume: 47 | Issue: 9 | Pages: 1194-1200

10.1097/ccm.0000000000003818 | PMID 31241499 Get It

Objectives: Data are lacking regarding implementation of novel strategies such as follow-up clinics and peer support groups, to reduce the burden of postintensive care syndrome. We sought to discover enablers that helped hospital-based clinicians establish post-ICU clinics and peer support programs, and identify barriers that challenged them. Design: Qualitative inquiry. The Consolidated Framework for Implementation Research was used to organize and analyze data. Setting: Two learning collaboratives (ICU follow-up clinics and peer support groups), representing 21 sites, across three continents. Subjects: Clinicians from 21 sites. Measurement and Main Results: Ten enablers and nine barriers to implementation of “ICU follow-up clinics” were described. A key enabler to generate support for clinics was providing insight into the human experience of survivorship, to obtain interest from hospital administrators. Significant barriers included patient and family lack of access to clinics and clinic funding. Nine enablers and five barriers to the implementation of “peer support groups” were identified. Key enablers included developing infrastructure to support successful operationalization of this complex intervention, flexibility about when peer support should be offered, belonging to the international learning collaborative. Significant barriers related to limited attendance by patients and families due to challenges in creating awareness, and uncertainty about who might be appropriate to attend and target in advertising. Conclusions: Several enablers and barriers to implementing ICU follow-up clinics and peer support groups should be taken into account and leveraged to improve ICU recovery. Among the most important enablers are motivated clinician leaders who persist to find a path forward despite obstacles.
Radio-Frequency Identification Specimen Tracking to Improve Quality in Anatomic Pathology
Norgan, Andrew P. , Simon, Kurt E., Feehan, Barbara A., Saari, Lynn L., Doppler, Joseph M., Welder, G. Scott, Sedarski, John A., Yoch, Christopher T., Comfere, Nneka I. , Martin, John A. , Bartholmai, Brian J. , Reichard, R. Ross , Bartholmai, Brian J , Norgan, Andrew P

Mayo Clinic

Archives of Pathology & Laboratory Medicine | June 27, 2019 | Volume: 144 | Issue: 2 | Pages: 189-195

10.5858/arpa.2019-0011-oa | PMID 31246113 Get It

Context.— Preanalytic errors, including specimen labeling errors and specimen loss, occur frequently during specimen collection, transit, and accessioning. Radio-frequency identification tags can decrease specimen identification and tracking errors through continuous and automated tracking of specimens. Objective.— To implement a specimen tracking infrastructure to reduce preanalytic errors (specimen mislabeling or loss) between specimen collection and laboratory accessioning. Specific goals were to decrease preanalytic errors by at least 70% and to simultaneously decrease employee effort dedicated to resolving preanalytic errors or investigating lost specimens. Design.— A radio-frequency identification specimen-tracking system was developed. Major features included integral radio-frequency identification labels (radio-frequency identification tags and traditional bar codes in a single printed label) printed by point-of-care printers in collection suites; dispersed radio-frequency identification readers at major transit points; and systems integration of the electronic health record, laboratory information system, and radio-frequency identification tracking system to allow for computerized physician order entry driven label generation, specimen transit time tracking, interval-based alarms, and automated accessioning. Results.— In the 6-month postimplementation period, 6 mislabeling events occurred in collection areas using the radio-frequency identification system, compared with 24 events in the 6-month preimplementation period (75% decrease; P = .001). In addition, the system led to the timely recovery of 3 lost specimens. Labeling expenses were decreased substantially in the transition from high-frequency to ultrahigh frequency radio-frequency identification tags. Conclusions.— Radio-frequency identification specimen tracking prevented several potential specimen-loss events, decreased specimen recovery time, and decreased specimen labeling errors. Increases in labeling/tracking expenses for the system were more than offset by time savings and loss avoidance through error mitigation.
National Association of Medical Examiners Position Paper: Recommendations for the Postmortem Assessment of Suspected Head Trauma in Infants and Young Children
Andrew, Thomas, Gilliland, M.G.F., Matshes, Evan W., Reichard, R. Ross , Gill, James Ritchie , Love, Jennifer

Mayo Clinic

Academic Forensic Pathology | June 26, 2019 | Volume: 4 | Issue: 2 | Pages: 206-213

10.23907/2014.032 Get It

The National Association of Medical Examiners convened a panel to create a position paper for recommendations for the investigation of infant deaths due to inflicted head trauma. The correct certification of both the cause and manner of death is dependent upon an evaluation of all available data including information derived from the investigation, scene, postmortem examination, and ancillary studies. This paper provides recommendations for the forensic pathologist on what constitutes the dataset to be produced during the postmortem examination of infants who have died of, or have apparently died of, inflicted head trauma. Specifically, this paper describes 1) procedures, 2) ancillary laboratory tests, and 3) forms of documentation that are important in the investigation of these deaths. The evaluation and documentation of such infant deaths involves the production of a detail oriented and thoroughly documented examination that is independently reviewable to support the multitude of inquiries that may follow from the public and the criminal justice system.
Upper and lower thresholds of fat-free mass index in a large cohort of female collegiate athletes
Harty, Patrick S. , Zabriskie, Hannah A. , Stecker, Richard A., Currier, Brad S. , Moon, Jessica M. , Kerksick, Chad M. , Jagim, Andrew R , Kerksick, Chad M , Harty, Patrick S , Zabriskie, Hannah A , Currier, Bradley S , Jagim, Andrew R.

Mayo Clinic

Journal of Sports Sciences | June 26, 2019 | Volume: 37 | Issue: 20 | Pages: 2381-2388

10.1080/02640414.2019.1634964 | PMID 31238804 Get It

Loss of succinate dehydrogenase B immunohistochemical expression distinguishes pulmonary chondromas from hamartomas
Chatzopoulos, Kyriakos , Fritchie, Karen , Aubry, Marie‐Christine, Carney, J Aiden, Folpe, Andrew L. , Fritchie, Karen J. , Boland, Jennifer M. , Aubry, Marie-Christine

Mayo Clinic

Histopathology | June 25, 2019 | Volume: 75 | Issue: 6 | Pages: 825-832

10.1111/his.13945 | PMID 31236950 Get It

AimsPulmonary chondromas, which are rare cartilaginous neoplasms that often arise in the setting of Carney triad, are morphologically similar to pulmonary hamartomas, which are much more common. There is evidence that succinate dehydrogenase (SDH) deficiency drives neoplasia in patients with Carney triad, and SDHB immunohistochemistry can be used as a surrogate marker to detect SDH deficiency. The aim of this study was to investigate the utility of SDHB immunohistochemistry in distinguishing pulmonary chondromas from hamartomas.Methods and resultsImmunohistochemistry for SDHB (clone 21A11AE7) was performed on histological sections from six cases of pulmonary chondroma and 33 cases of pulmonary hamartoma. SDHB expression was retained in all 33 pulmonary hamartomas, and lost in the majority of evaluable chondromas (five of six). Of the five patients with chondromas showing SDHB loss, four had definitive Carney triad. Most patients with pulmonary hamartomas were older males with small solitary masses, whereas chondromas often presented as multiple masses in young females.ConclusionLoss of SDHB immunohistochemical expression can be useful for differentiating pulmonary chondromas from hamartomas, and potentially identifying patients with Carney triad.
RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer
Gbenedio, Oghenekevwe M. , Bonnans, Caroline , Grün, Delphine , Wang, Chih‐Yang , Hatch, Ace J. , Mahoney, Michelle R., Matli, Mary, Miao, Yi , García, K. Christopher , Delorenzi, Mauro , Warren, Robert S. , Roose, Jeroen P. , Depeille, Philippe , Nixon, Andrew B. , Barras, David , Tejpar, Sabine , Venook, Alan P.

Mayo Clinic

JCI Insight | June 25, 2019 | Volume: 4 | Issue: 15 | Pages: No page available

10.1172/jci.insight.127552 | PMID 31237864 Get It

Colorectal cancer (CRC) is the third most frequent neoplastic disorder and is a main cause of tumor-related mortality, as many patients progress to stage IV metastatic CRC. Standard care consists of combination chemotherapy (FOLFIRI or FOLFOX). Patients with WT KRAS typing are eligible to receive anti-EGFR therapy combined with chemotherapy. Unfortunately, predicting efficacy of CRC anti-EGFR therapy has remained challenging. Here we uncovered that the EGFR pathway component RasGRP1 acts as a CRC tumor suppressor in the context of aberrant Wnt signaling. We found that RasGRP1 suppresses EGF-driven proliferation of colonic epithelial organoids. Having established that RasGRP1 dosage levels impact biology, we next focused on CRC patients. Mining 5 different data platforms, we establish that RasGRP1 expression levels decrease with CRC progression and predict poor clinical outcome of patients. Last, deletion of 1 or 2 Rasgrp1 alleles made CRC spheroids more susceptible to EGFR inhibition. Retrospective analysis of the CALGB 80203 clinical trial showed that addition of anti-EGFR therapy to chemotherapy significantly improved outcome for CRC patients when tumors expressed low levels of RasGRP1 suppressor. In sum, our data support RasGRP1 as a biomarker in the EGFR pathway that has potential relevance to anti-EGFR therapy for CRC patients.
HepaticYAP1-TFE3Rearranged Epithelioid Hemangioendothelioma
Lotfalla, Mira , Folpe, Andrew L. , Fritchie, Karen , Galliano, Gretchen G., Halling, Kevin C. , Mounajjed, Taofic, Torres‐Mora, Jorge , Graham, Rondell P. , Lotfalla, Mira M , Fritchie, Karen J. , Torres-Mora, Jorge, Graham, Rondell P , Greipp, Patricia T. , Galliano, Gretchen E.

Mayo Clinic

Case Reports in Gastrointestinal Medicine | June 23, 2019 | Volume: 2019 | Issue: No issue available | Pages: 1-5

10.1155/2019/7530845 | PMID 31341686 Get It

Epithelioid hemangioendothelioma (EHE) is an uncommon low-grade malignant vascular tumor that may arise in soft tissue/bone or visceral sites such as the liver and lung. As this tumor exhibits epithelioid morphology, it frequently causes diagnostic confusion with other epithelioid vascular neoplasms as well as carcinoma. While 90% of classic EHE are driven by aWWTR1-CAMTA1fusion gene, a histologically distinctive subset of EHE has been recently shown to harbor a different fusion gene,YAP1-TFE3. This variant is likely underrecognized given its rarity and only recent description. Notably, EHE frequently involves the liver but only one case of hepaticYAP1-TFE3rearranged EHE has been reported to date. We present the second case ofYAP1-TFE3rearranged EHE affecting a 65-year-old woman and presenting as multiple liver masses, with characterization of the fusion gene at the transcriptomic and genomic levels. There are several educational points noted from this case.YAP1-TFE3rearranged EHE shows distinctly vasoformative foci, unlike classic EHE and mimicking angiosarcoma or epithelioid hemangioma. The tumors cells show a histiocytoid appearance with voluminous cytoplasm, similar to otherTFE3-rearranged tumors. Finally, in the liver, this tumor may in part mimic focal nodular hyperplasia of the liver which is an underrecognized diagnostic pitfall. This report highlights the key diagnostic and genetic features of this newly recognized variant of hepatic EHE to aid pathologists in appropriately classifying these tumors.
Implementation of a patient blood management program in hematopoietic stem cell transplantation (Editorial, p. 2763)
Warner, Matthew A. , Jambhekar, Nilesh S., Saadeh, Salwa , Jacob, Eapen K., Kreuter, Justin D. , Mundell, William C., Marquez, Alberto , Higgins, Andrew , Madde, Nageswar R., Kor, Daryl J. , Higgins, Andrew A, Warner, Matthew A , Higgins, Andrew A., Hogan, William J.

Mayo Clinic

Transfusion | June 21, 2019 | Volume: 59 | Issue: 9 | Pages: 2840-2848

10.1111/trf.15414 | PMID 31222775 Get It

BACKGROUNDRecipients of hematopoietic stem cell transplantation (HSCT) are among the highest consumers of allogeneic red blood cell (RBC) and platelet (PLT) components. The impact of patient blood management (PBM) efforts on HSCT recipients is poorly understood.STUDY DESIGN AND METHODSThis observational study assessed changes in blood product use and patient‐centered outcomes before and after implementing a multidisciplinary PBM program for patients undergoing HSCT at a large academic medical center. The pre‐PBM cohort was treated from January 1 through September 31, 2013; the post‐PBM cohort was treated from January 1 through September 31, 2015.RESULTSWe identified 708 patients; 284 of 352 (80.7%) in the pre‐PBM group and 225 of 356 (63.2%) in the post‐PBM group received allogeneic RBCs (p < 0.001). Median (interquartile range [IQR]) RBC volumes were higher before PBM than after PBM (3 [2‐4] units vs. 2 [1‐4] units; p = 0.004). A total of 259 of 284 pre‐PBM patients (91.2%) and 57 of 225 (25.3%) post‐PBM patients received RBC transfusions when hemoglobin levels were more than 7 g/dL (p < 0.001). The median (IQR) PLT transfusion quantities was 3 (2‐5) units for pre‐PBM patients and 2 (1‐4) units for post‐PBM patients (p < 0.001). For patients with PLT counts of more than 10 × 109/L, a total of 1219 PLT units (73.4%) were transfused before PBM and 691 units (48.8%) were transfused after PBM (p < 0.001). Estimated transfusion expenditures were reduced by $617,152 (18.3%). We noted no differences in clinical outcomes or transfusion‐related adverse events.CONCLUSIONPatient blood management implementation for HSCT recipients was associated with marked reductions in allogeneic RBC and PLT transfusions and decreased transfusion‐related costs with no detrimental impact on clinical outcomes.